Outcomes of surgical (pars plicata and limbal lensectomy, vitrectomy) and non-surgical management of persistent fetal vasculature (PFV): An analysis of 54 eyes

European Journal of Ophthalmology

Volumn 12, Issue 6, 2002, Pages 523-533

  Soheilian, M ^a,b   Vistamehr, S ^a   Rahmani, B ^a   Ahmadieh, H ^a   Azarmina, M ^a   Mashayekhi, A ^a   Sajjadi, H ^a   Dehghan, M H ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Congenital cataract; PFV (Persistent fetal vasculature); PHPV (Persistent hyperplastic primary vitreous); Vitrectomy

Indexed keywords

ADOLESCENT; ADULT; AMBLYOPIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONSANGUINEOUS MARRIAGE; EYE DISEASE; FEMALE; GLAUCOMA; HUMAN; LENSECTOMY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERSISTENT FETAL VASCULATURE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA TEAR; SURGICAL TECHNIQUE; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE; CONGENITAL MALFORMATION; EYE MALFORMATION; HYPERPLASIA; INFANT; LENS; NEWBORN; PATHOLOGY; PERSISTENT FETUS CIRCULATION; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; TREATMENT OUTCOME; VASCULARIZATION; VITREOUS BODY;

CHILD, PRESCHOOL; EYE ABNORMALITIES; FEMALE; HUMANS; HYPERPLASIA; INFANT; INFANT, NEWBORN; LENS, CRYSTALLINE; MALE; PERSISTENT FETAL CIRCULATION SYNDROME; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 0036877511     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210201200613     Document Type: Article

References (25)

1. Goldberg MF. Persistent fetal vasculature (PFV): An integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PH-PV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 1997; 124: 585-626.
2. Reese AB. Persistent hyperplastic primary vitreous. Trans Am Acad Ophthalmol Otolaryngol 1955; 59: 271-95.
3. Pollard ZF. Results of treatment of persistent hyperplastic primary vitreous. Ophthalmic Surg 1991; 22: 48-52.
4. Scott WE, Drummond GT, Keech RV, Karr DJ. Management and visual acuity results of monocular congenital cataract and persistent hyperplastic primary vitreous. Aust NZJ Ophthalmol 1989; 17: 143-52.
5. Peyman GA & Schulman JA. Intravitreal surgery. In: Principles and practice, 2nd ed. Norwalk Connecticut: Appleton & Lange, 1994; 234: 399-401.
6. Mittra RA, Huynh LT, Ruttum MS, et al. Visual outcomes following lensectomy and vitrectomy for combined anterior and posterior persistent hyperplastic primary vitreous. Arch Ophthalmol 1998; 116: 1190-4.
7. Dass AB, Trese MT. Surgical results of persistent hyperplastic primary vitreous. Ophthalmology 1999; 106: 280-4.
8. Alexandrakis G, Scott IU, Flynn HW, Murray G, Feuer WJ. Visual acuity outcomes with and without surgery in patients with persistent fetal vasculature. Ophthalmology 2000; 107: 1068-72.
9. Goldberg MF, Peyman GA. Pars plicata surgery in the child for pupillary membranes, persistent hyperplastic primary vitreous and infantile cataract, Transaction of the New Orleans Academy of Ophthalmology, Symposium on medical and surgical diseases of the retina and vitreous. St. Louis: CV Mosby, 1983; 20.
10. Pollard ZF. Treatment of persistent hyperplastic primary vitreous. J Pediatr Ophthalmol Strabismus 1985; 22: 180-3.
11. Peyman GA, Sanders DR, Napgal KC. Management of persistent hyperplastic primary vitreous by pars plana vitrectomy. Br J Ophthalmol 1976; 60: 756-8.
12. Smith RE, Maumenee AE. Persistent hyperplastic primary vitreous: Results of surgery. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 911-24.
13. Federman JL, Shields JA, Altman B, Koller H. The surgical and nonsurgical management of persistent hyperplastic primary vitreous. Ophthalmology 1982; 89: 20-4.
14. Cheung JC, Summers GC, Young TL. Myopia predicts better outcome in persistent hyperplastic primary vitreous. J Pediatr Ophthalmol Strabismus 1997; 34: 170-6.
15. Karr DJ, Scott WE. Visual acuity results following treatment of persistent hyperplastic primary vitreous. Arch Ophthalmol 1986; 104: 662-7.
16. SAS Institute Inc. SAS/STAT guide for personal computers. Version 6 edition. Cary, NC: SAS Institute Inc., 1987.
17. Pruett RC. Persistent hyperplastic primary vitreous. In: Fraunfeld, FT. Current ocular therapy. Philadelphia: WB Saunders, 1995; 743-51.
18. Akiya S, Uemura Y, Azuma N. Morphological study on human developing vitreous collagen fibrils and persistent hyperplastic primary vitreous. Ophthalmic Res 1985; 17: 60-4.
19. Haddad R, Font RL, Reeser F. Persistent hyperplastic primary vitreous. A clinicopathologic study of 62 cases and review of the literature. Surv Ophthalmol 1978; 23: 123-33.
20. Akiya S, Uemura Y, Tsuchiaya S, Azunma N, Fujita K. Electron microscopy study of the developing human vitreous collagen fibrils. Ophthalmic Res 1986; 18: 199-202.
21. Spitznas M, Koch F, Pohl S. Ultrastructural pathology of anterior persistent hyperplastic primary vitreous. Graefes Arch Clin Exp Ophthalmol 1990; 228: 487-96.
22. Caudill JW, Streeten BW, Tso MOM. Phacoanaphylactoid reaction in persistent hyperplastic primary vitreous. Ophthalmology 1985; 92: 1153-8.
23. Kaste SC, Jenkins III JJ, Meyer D, et al. Persistent hyperplastic primary vitreous of the eye: Imaging findings with pathologic correlation. Am J Roentgenol 1994; 162: 437-40.
24. Goldberg MF, Mafee M. Computed tomography for diagnosis of persistent hyperplastic primary vitreous (PFV). Ophthalmology 1983; 90: 442-51.
25. Mafee MF, Goldberg MF. Persistent hyperplastic primary vitreous (PFV): Role of computed tomography and magnetic resonance. Radiol Clin North Am 1987; 25: 683-92.